This activity is hosted on the site of our educational partner
You will be connecting to our educational partner, which controls its own content, practices, and other policies.
You will be connecting to our educational partner, which controls its own content, practices, and other policies.
Initial Management Strategies for Overactive Bladder
Powered by
Format
Audio
Time to Complete
30 minutes
Released
January 12, 2018
Expires
January 11, 2019
Maximum Credits
0.50 / AMA PRA Category 1 Credit(s)TM
Accredited Provider
Provided by Haymarket Medical Education (HME)
Commercial Supporter
Supported by Astellas Pharma US, Inc.
Program Description
Optimal treatment for overactive bladder (OAB) incorporates different modalities, depending largely on the specific needs of the patient. For many individuals, a combination of lifestyle interventions and pharmacologic therapy is required for adequate relief of symptoms. Despite the existence of safe and effective therapies, fewer than one third of patients with OAB currently receive treatment. Of those who are treated, many prematurely discontinue therapy, oftentimes because of bothersome side effects.
In this activity, a urologist and a primary care provider discuss care options for a 69-year-old woman with various health comorbidities who has been experiencing OAB symptoms for the past several years. The faculty review evidence-based options for alleviating persistent bladder symptoms in this patient, as well as considerations for the selection of therapy. Strategies for keeping the patient engaged in care and adherent to therapy over the long term are also discussed.
In this activity, a urologist and a primary care provider discuss care options for a 69-year-old woman with various health comorbidities who has been experiencing OAB symptoms for the past several years. The faculty review evidence-based options for alleviating persistent bladder symptoms in this patient, as well as considerations for the selection of therapy. Strategies for keeping the patient engaged in care and adherent to therapy over the long term are also discussed.
Intended Audience
Urologists, urologic healthcare professionals, primary care clinicians (MDs/DOs, PAs, NPs) and OB-GYNs
Educational Objectives
After completing the activity, the participant should be better able to:
- Employ individualized treatment strategies for initial management of OAB symptoms
- Utilize effective communication strategies with patients with OAB to foster therapeutic adherence
Conflict Of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.
Faculty
Matt T. Rosenberg, MD
Medical Director
Mid-Michigan Health Centers
Jackson, MI
Dr. Rosenberg is a consultant and stock holder for OPKD and serves on the Speaker’s Bureau for Astellas.
David Ginsberg, MD
Associate Professor of Clinical Urology
Keck School of Medicine
University of Southern California
Los Angeles, CA
Dr. Ginsberg has no relevant financial relationships to disclose.
Medical Director
Mid-Michigan Health Centers
Jackson, MI
Dr. Rosenberg is a consultant and stock holder for OPKD and serves on the Speaker’s Bureau for Astellas.
David Ginsberg, MD
Associate Professor of Clinical Urology
Keck School of Medicine
University of Southern California
Los Angeles, CA
Dr. Ginsberg has no relevant financial relationships to disclose.
Accredited Provider Disclosures
Haymarket Medical Education staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.
Credit
0.50
Type
AMA PRA Category 1 Credit(s)TM
Accreditation Statement
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
Haymarket Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.
Disclaimer
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education or Astellas Pharma US, Inc.. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Instructions
In order to receive credit for this activity, the participant must complete the pre-activity questionnaire, post-test, and program evaluation. Participants must also score at least 70% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.
If you have any questions relating to the accreditation of this activity, please contact cmequestions@haymarketmedical.com.
If you have any other questions relating to your certificate or other issues with the activity, please contact
myCME.Support@haymarketmedical.com.
If you have any questions relating to the accreditation of this activity, please contact cmequestions@haymarketmedical.com.
If you have any other questions relating to your certificate or other issues with the activity, please contact
myCME.Support@haymarketmedical.com.
Privacy Policy
SYSTEM REQUIREMENTS
Hardware and Software Requirements
- A computer with an internet connection
- Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
- Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required